White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

Pharmacological characterisation of GABA receptors in potential spinal cord neural stem cells

Shafin, Nazlahshaniza (2019) Pharmacological characterisation of GABA receptors in potential spinal cord neural stem cells. PhD thesis, University of Leeds.

[img]
Preview
Text
Shafin_N_Biomedical_PhD_ 2019.pdf - Final eThesis - complete (pdf)
Available under License Creative Commons Attribution-Noncommercial-Share Alike 2.0 UK: England & Wales.

Download (3093Kb) | Preview

Abstract

Modulation of GABA mediated inhibition is one of the most important approaches for the treatment of central nervous system (CNS) diseases. Precise targeting of such treatments depends on identification and characterisation of the different subunit complexes that exist. In the CNS, there are pools of neural stem cells (NSC), which can differentiate to become neurones, astrocytes or oligodendrocytes while progenitor cells have limited lineage. In addition to brain regions, where NSCs are now known to exist, the spinal cord area also has a neurogenic potential in the form of ependymal cells. Ependymal cells surrounding the central canal displayed typical properties of glial cells; lack of voltage-gated channels, and showed coupling indicative of the presence of gap junction. Ependymal cells showed responses to GABA as previously observed(Corns et al., 2013). The effects of GABA on ependymal cells were concentration dependant.Ependymal cells in our study showed atypical GABA receptors since it was not fully blocked by GABAA receptor antagonist; bicuculline. Hyperpolarising responses to low GABA were antagonised by the GABAρ receptor antagonist, (1, 2, 5, 6- Tetrahydropyridin-4-yl) methylphosphinic acid (TPMPA). On further confirmation of this, Trans-4-aminocrotonic acid (TACA), a selective agonist of GABAρ1 elicited robust and reproducible hyperpolarising responses, similar to those observed with low concentrations of GABA. This provides evidence of a combination or coassembly of GABAA and ρ receptors in the ependymal cells or the presence of two different receptors. One potential site of modulation of GABA receptors is through diazepam binding inhibitor (DBI). DBI with its breakdown product, octadecaneurapeptide (ODN) acts as positive and negative modulator at central benzodiazepine receptor (CBR). The responses to high concentrations of GABA were modulated by midazolam suggesting a potential involvement of CBR and another receptor, Translocator Protein (TSPO). On testing TSPO, N, N-Dihexyl-2-(4-fluorophenyl) indole-3-acetamide (FGIN-1-27); selective agonist at TSPO, increased the responses in ependymal cells to the higher concentration of GABA. When combining FGIN-1-27 with 1-(2-Chlorophenyl)-Nmethyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK-11195); a selective TSPO antagonist, the augmented GABA responses were not observed, suggesting that this effect was due to activation of TSPO. These results indicate that modulation of GABA receptors by midazolam occurred at both CBR and TSPO. However, the responses of GABA in the presence of ODN (20 µM) did not show significant changes regardless of the GABA concentration used. Nanomolar ODN application alone causes fast hyperpolarisations similar to low GABA and TACA effects. Responses to nanomolar ODN were significantly but not fully blocked by cyclo1-8[dleu5] OP (cDLOP), an ODN metabotropic receptor antagonist. ODN is somehow directly activating the GABA receptors that contain rho subunits since the hyperpolarising effects of ODN were significantly blocked by TPMPA. So there is an evidence there are atypical GABA receptors responsible for this action with ODN. Baclofen (a selective GABAB receptor agonist) also hyperpolarised ependymal cells, an effect antagonised by CGP 55845 (GABAB antagonist), indicating a further role for GABAB receptors on ependymal cells. The numbers of proliferative cells in the central canal region were significantly lower in baclofen treated slices compared with control. Activation of the 5-HT receptor caused both depolarisation and hyperpolarisation contribute to the proliferative capabilities of ependymal cells. Blockade of 5-HT receptor mediated depolarisations with cinanserin showed the presence of 5-HT2 receptors in the spinal cord. Furthermore, hyperpolarisations with 8-OH-DPAT and cisapride indicate that 5-HT 1A and 5-HT4 receptors are also present in the central canal area of spinal cord. Overall, our study has shown a complex and varied response profile of ependymal cells to GABA and its modulators. This could have important implications in the proliferative capabilities of spinal cord neural stem cells and thus functional consequences. The modulation of proliferation and differentiation by GABA may be an interesting future therapeutic target for conditions where there is over proliferation such as in spinal cord ependymomas or in conditions such as in multiple sclerosis where replacement cells may be useful to aid recovery.

Item Type: Thesis (PhD)
Keywords: GABA receptor, ligand gated, metabotropic receptor, serotonin receptor spinal cord
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds)
Identification Number/EthosID: uk.bl.ethos.789437
Depositing User: Nazlahshaniza Shafin
Date Deposited: 31 Oct 2019 09:21
Last Modified: 18 Feb 2020 12:51
URI: http://etheses.whiterose.ac.uk/id/eprint/24700

You do not need to contact us to get a copy of this thesis. Please use the 'Download' link(s) above to get a copy.
You can contact us about this thesis. If you need to make a general enquiry, please see the Contact us page.

Actions (repository staff only: login required)